A Phase 1b trial shows the higher dose of pociredir boosts fetal hemoglobin levels in adults with sickle cell disease.
Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...
The next 12 months will tell us more about their prospects.
The National Coordinator, Association of Persons Living with Sickle Cell Disease, Mrs Aisha Edwards Maduagwu has raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback